Singh S, Davenport K, Schooley E, Ruggiero A, Nassar S, Buch J
Viruses. 2023; 15(10).
PMID: 37896893
PMC: 10612086.
DOI: 10.3390/v15102117.
Frankenfeld J, Meili T, Meli M, Riond B, Helfer-Hungerbuehler A, Bonzli E
Viruses. 2019; 11(8).
PMID: 31370217
PMC: 6722909.
DOI: 10.3390/v11080697.
Beczkowski P, Hughes J, Biek R, Litster A, Willett B, Hosie M
J Gen Virol. 2014; 96(Pt 4):893-903.
PMID: 25535323
PMC: 4361796.
DOI: 10.1099/vir.0.000035.
Sundstrom M, White R, de Parseval A, Sastry K, Morris G, Grant C
J Virol. 2008; 82(18):9134-42.
PMID: 18596086
PMC: 2546885.
DOI: 10.1128/JVI.00394-08.
Giannecchini S, DUrsi A, Esposito C, Scrima M, Zabogli E, Freer G
Clin Vaccine Immunol. 2007; 14(8):944-51.
PMID: 17596431
PMC: 2044484.
DOI: 10.1128/CVI.00140-07.
Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope.
de Parseval A, Grant C, Sastry K, Elder J
J Virol. 2006; 80(6):3088-91.
PMID: 16501119
PMC: 1395450.
DOI: 10.1128/JVI.80.6.3088-3091.2006.
Vaccination with inactivated virus but not viral DNA reduces virus load following challenge with a heterologous and virulent isolate of feline immunodeficiency virus.
Hosie M, Dunsford T, Klein D, Willett B, Cannon C, Osborne R
J Virol. 2000; 74(20):9403-11.
PMID: 11000209
PMC: 112369.
DOI: 10.1128/jvi.74.20.9403-9411.2000.
The capsid gene of feline calicivirus contains linear B-cell epitopes in both variable and conserved regions.
Radford A, Willoughby K, Dawson S, McCracken C, Gaskell R
J Virol. 1999; 73(10):8496-502.
PMID: 10482602
PMC: 112869.
DOI: 10.1128/JVI.73.10.8496-8502.1999.
Variable constraints on the principal immunodominant domain of the transmembrane glycoprotein of human immunodeficiency virus type 1.
Merat R, Raoul H, Leste-Lasserre T, Sonigo P, Pancino G
J Virol. 1999; 73(7):5698-706.
PMID: 10364320
PMC: 112629.
DOI: 10.1128/JVI.73.7.5698-5706.1999.
Development of a Western blot assay for detection of bovine immunodeficiency-like virus using capsid and transmembrane envelope proteins expressed from recombinant baculovirus.
Abed Y, St-Laurent G, Zhang H, Jacobs R, Archambault D
Clin Diagn Lab Immunol. 1999; 6(2):168-72.
PMID: 10066648
PMC: 95681.
DOI: 10.1128/CDLI.6.2.168-172.1999.
DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.
Hosie M, Flynn J, Rigby M, Cannon C, Dunsford T, Mackay N
J Virol. 1998; 72(9):7310-9.
PMID: 9696827
PMC: 109955.
DOI: 10.1128/JVI.72.9.7310-7319.1998.
Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus.
Richardson J, Moraillon A, Crespeau F, Baud S, Sonigo P, Pancino G
J Virol. 1998; 72(3):2406-15.
PMID: 9499101
PMC: 109540.
DOI: 10.1128/JVI.72.3.2406-2415.1998.
Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope.
Richardson J, Moraillon A, Baud S, Cuisinier A, Sonigo P, Pancino G
J Virol. 1997; 71(12):9640-9.
PMID: 9371628
PMC: 230272.
DOI: 10.1128/JVI.71.12.9640-9649.1997.
Retention of viral infectivity after extensive mutation of the highly conserved immunodominant domain of the feline immunodeficiency virus envelope.
Pancino G, Sonigo P
J Virol. 1997; 71(6):4339-46.
PMID: 9151822
PMC: 191650.
DOI: 10.1128/JVI.71.6.4339-4346.1997.
Extensive sequence variation of feline immunodeficiency virus env genes in isolates from naturally infected cats.
Greene W, Meers J, del Fierro G, Carnegie P, Robinson W
Arch Virol. 1993; 133(1-2):51-62.
PMID: 8240017
DOI: 10.1007/BF01309743.
Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.
Baldinotti F, Matteucci D, Mazzetti P, Giannelli C, Bandecchi P, Tozzini F
J Virol. 1994; 68(7):4572-9.
PMID: 8207831
PMC: 236384.
DOI: 10.1128/JVI.68.7.4572-4579.1994.
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns.
Sodora D, Shpaer E, Kitchell B, Dow S, Hoover E, Mullins J
J Virol. 1994; 68(4):2230-8.
PMID: 8139008
PMC: 236699.
DOI: 10.1128/JVI.68.4.2230-2238.1994.
A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.
Lombardi S, Garzelli C, Pistello M, Massi C, Matteucci D, Baldinotti F
J Virol. 1994; 68(12):8374-9.
PMID: 7966629
PMC: 237306.
DOI: 10.1128/JVI.68.12.8374-8379.1994.
Antibody reactivity to the immunodominant epitopes of the caprine arthritis-encephalitis virus gp38 transmembrane protein associates with the development of arthritis.
Bertoni G, Zahno M, Zanoni R, Vogt H, Peterhans E, Ruff G
J Virol. 1994; 68(11):7139-47.
PMID: 7933096
PMC: 237153.
DOI: 10.1128/JVI.68.11.7139-7147.1994.
Structural analysis of the principal immunodominant domain of the feline immunodeficiency virus transmembrane glycoprotein.
Pancino G, Camoin L, Sonigo P
J Virol. 1995; 69(4):2110-8.
PMID: 7884857
PMC: 188877.
DOI: 10.1128/JVI.69.4.2110-2118.1995.